Ilmatar Rooda

Ilmatar Rooda

Auto-generated profile, based on publicly available information

Ilmatar Rooda

Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
IRIlmatar Rooda
Ilmatar Rooda
JHJasmin Hassan
Jasmin Hassan
JHJie Hao
Jie Hao
MWMagdalena Wagner
Magdalena Wagner
EMElisabeth Moussaud-Lamodière
Elisabeth Moussaud-Lamodière
PDPauliina Damdimopoulou
Pauliina Damdimopoulou
The ovarian cortical reserve of follicles is vital for fertility. Some medical treatments are toxic to follicles, leading to premature ovarian insufficiency. Ovarian tissue cryopreservation is an established method to preserve fertility in adults and even applied in prepuberty despite unproven efficacy. Here, we analyze transcriptomes of 120 cortical follicles from children and adults for detailed comparison. We discover heterogeneity with two main types of follicles in both age groups: one with expected oocyte-granulosa profiles and another with predicted role in signaling. Transcriptional changes during growth to the secondary stage are similar overall in children and adults, but variations related to extracellular matrix, theca cells, and miRNA profiles are found. Notably, cyclophosphamide dose correlates with interferon signaling in child follicles. Additionally, morphology alone is insufficient for follicle categorization suggesting a need for additional markers. Marker genes for early follicle activation are determined. These findings will help refine follicular classification and fertility preservation techniques across critical ages.

11 August 2026 in Human Reproduction
Verified
Journal Article
Open access
LLL Luyckx
L Luyckx
MMM Myllykangas
M Myllykangas
JKJ Kinnunen
J Kinnunen
SLS Lukashevich
S Lukashevich
ASAndres Salumets
Andres Salumets
TPT T Piltonen
T T Piltonen
STUDY QUESTION: Does the endometrium of oligo-ovulatory women with polyendocrine metabolic ovarian syndrome (PMOS) exhibit menstrual cycle phase-specific transcriptomic alterations compared to women without PMOS? SUMMARY ANSWER: Compared to healthy controls, women with PMOS exhibit endometrial transcriptomic dysregulations which are menstrual cycle phase-specific and, most notably, related to mitochondrial function. WHAT IS KNOWN ALREADY: Infertility and gestational dysfunction in women with PMOS are increasingly attributed to endometrial abnormalities, yet the underlying mechanisms behind PMOS-related endometrial dysfunction remain unclear. Previous studies have focused on anovulatory phenotypes, resulting in a poor understanding of cycle phase-specific defects in the endometria of women with PMOS. STUDY DESIGN, SIZE, DURATION: Endometrial biopsies were obtained from oligo-ovulatory women with PMOS and healthy controls at four distinct menstrual cycle phases (proliferative, early-, mid-, and late-secretory phases) and subjected to RNA sequencing. Parallel in vitro experiments were conducted using cultured endometrial stromal cells (ESCs) and epithelial organoids (EEOs) derived from an additional endometrial sample cohort. PARTICIPANTS/MATERIALS, SETTING, METHODS: RNA sequencing was performed on biopsies from 78 (oligo-)ovulatory women, age- and BMI-matched between PMOS (n = 39) and control (n = 39) groups. Phase-specific transcriptomic profiles and pathway enrichment analyses were performed. For functional assays, endometrial cells were isolated from four PMOS and four control donors per BMI group (lean: < 25 kg/m2; obese: ≥30 kg/m2). Mitochondrial function, including respiration, ATP and reactive oxygen species production, and membrane potential, was assessed in both cell types before and after hormonal exposure. MAIN RESULTS AND THE ROLE OF CHANCE: Endometrial transcriptomes clustered primarily by cycle phase; however, PMOS-specific dysregulation was observed related to extracellular matrix organization, estrogen receptor (ESR) signaling, ion transport, and mitochondrial respiratory function. Gene trajectory analyses revealed phase-specific alterations in progesterone-, insulin signaling-, and mitochondria-related gene expression during the early-secretory phase, and epithelial function during the mid-secretory phase. Functionally, decidualized ESCs from obese PMOS women displayed reduced mitochondrial respiration, whereas EEOs from lean PMOS patients exhibited increased mitochondrial activity. LARGE SCALE DATA: Sequencing data are available from the corresponding author upon request. LIMITATIONS, REASONS FOR CAUTION: Women with PMOS were oligo-ovulatory while controls exhibited regular cycles. The sample size for in vitro studies was modest, warranting validation in larger cohorts. Additionally, the use of bulk RNA sequencing may obscure cell-type-specific transcriptomic signatures, emphasizing the need for future single-cell approaches to dissect cellular heterogeneity in PMOS endometrium. WIDER IMPLICATIONS OF THE FINDINGS: This study uncovers dynamic, cycle phase-dependent molecular and bioenergetic alterations in the endometrium of oligo-ovulatory women with PMOS. Mitochondrial dysfunction, particularly during the implantation window, emerges as a key pathological feature. The observed BMI-dependent divergence in mitochondrial function suggests that personalized therapeutic strategies may be necessary to improve reproductive outcomes in women with PMOS. FUNDING: Funded by the Jusélius Foundation, Novo Nordisk Foundation, Research Council of Finland, and the Horizon 2020 Marie-Curie MATER Innovative Training Network (all to T.T.P.), with additional support from the University of Oulu Scholarship Foundation (L.L.), the Estonian Research Council (E.V.M. and I.R.), and the Estonian Research Council grant no. PRG1076, Swedish Research Council grant no. 2024-02530, Novo Nordisk Foundation grant no. NNF24OC0092384 and Horizon Europe grant NESTOR, grant no. 101120075 (A.S.). DISCLOSURES: The authors declare no competing interests.

7 March 2026 in medRxiv
Verified
Preprint
Open access
PDF file
AAApostol Ganchev Apostolov
Apostol Ganchev Apostolov
APAmruta D. S. Pathare
Amruta D. S. Pathare
DLDarja Lavogina
Darja Lavogina
CZCheng Zhao
Cheng Zhao
KKKeiu Kask
Keiu Kask
ASAndres Salumets
Andres Salumets
The use of semaglutide (SE), a glucagon-like peptide-1 receptor agonist (GLP-1RA) with glucose-lowering and weight-loss effects, has risen rapidly, particularly among women of reproductive age. While preclinical studies suggest benefits for ovarian function via the hypothalamic–pituitary–ovarian axis, its impact on the endometrial–embryo interface remains unclear. Here, we show that GLP-1R is dynamically expressed in fertile human endometrium, restricted to epithelial cells and markedly upregulated during the mid-secretory phase of the menstrual cycle. In a preclinical model of endometrial epithelial organoids, SE at physiological concentrations activates intracellular cAMP signaling, enhances epithelial metabolism, and upregulates receptivity markers without steroid hormone priming, whereas higher concentrations modestly reduce expression of a key receptivity marker PAEP /glycodelin and shift metabolism towards oxidative phosphorylation. By contrast, in stromal cells lacking detectable GLP-1R, SE disrupts decidualization, induces endoplasmic reticulum stress and suppresses cell-cycle at G2/M phase. Human embryo models, blastoids, expressed GLP-1R and underwent concordant SE-mediated transcriptional remodeling in epiblast and trophectoderm lineages, encompassing changes in metabolism and epigenetic regulation, but without shifts in lineage proportions. Notably, SE increased blastoid attachment to the endometrial epithelium in the absence of exogenous steroid hormones, suggesting enhanced epithelial–embryo interaction. Together, these findings reveal a compartment-specific mismatch, as SE augments epithelial and embryonic metabolic activity but compromises stromal support for implantation, with potential consequences for implantation due to stromal dysfunction.

2 April 2026 in medRxiv
Verified
Preprint
Open access
PDF file
DLDarja Lavogina
Darja Lavogina
AAApostol Ganchev Apostolov
Apostol Ganchev Apostolov
SRSanjiv Risal
Sanjiv Risal
PMPaula Iglesias Moreno
Paula Iglesias Moreno
APAmruta D. S. Pathare
Amruta D. S. Pathare
ASAndres Salumets
Andres Salumets
Human embryo implantation, occurring approximately one week after fertilization, remains poorly understood due to ethical and technical limitations of in vivo investigation. To overcome these barriers, and model this critical developmental event, encompassing peri- and early post-implantation stages, we used an in vitro embryo attachment model composed of donor-derived endometrial epithelial cells forming an open-faced endometrial layer (OFEL) and human stem cell-derived blastoids recapitulating human day 5 blastocysts in peri-implantation model. Following attachment, developmental progression was further investigated on laminin-coated substrates to capture early post-implantation dynamics. Despite its central role as the primary endocrine signal of early pregnancy, human chorionic gonadotropin (hCG) remains largely uncharacterized in this context. Here, we describe the transcriptomic profile of blastoid–endometrial co-cultures relative to OFEL alone, identifying CGA and CGB3/5/8 as among the most strongly upregulated genes following blastoid attachment to hormonally stimulated OFEL. Consistent with these findings, immunoassays and luteinizing hormone/choriogonadotropin receptor (LHCGR) activation assays of conditioned media confirmed the secretion of heterodimeric, biologically active hCG and its free subunits in co-cultures, but not in endometrial layers alone. Notably, the hyperglycosylated hCG heterodimer was the predominant isoform detected. Co-culture with the endometrial component significantly increased hCG secretion compared with blastoids cultured alone, an effect further enhanced by hormonal priming in the peri-implantation model. Collectively, these findings indicate that a hormonally primed endometrial environment not only promotes blastoid attachment but also amplifies embryonic hCG production and bioactivity, underscoring the importance of maternal endocrine cues in early embryo-endometrium communication. Furthermore, our peri-and early post-implantation models recapitulate key aspects of reciprocal endocrine signaling between embryonic and endometrial tissues, providing a tractable experimental framework to investigate embryo–endometrium crosstalk.

22 March 2025 in Reproductive, Female and Child Health
Verified
Journal Article
Open access
IRIlmatar Rooda
Ilmatar Rooda
SASusanna Alder
Susanna Alder
LTLeonora Tebani
Leonora Tebani
SGSebastian Gidlöf
Sebastian Gidlöf
CACatarina Arnelo
Catarina Arnelo
PDPauliina Damdimopoulou
Pauliina Damdimopoulou
Background: Studying ovaries and follicles in detail is crucial to understanding their normal function and identifying factors contributing to ovarian disease and infertility. However, obtaining ovarian tissue for research is challenging, and instead of entire ovaries, small biopsies are often collected. In this study, we aimed to assess the surgical safety of ovarian biopsy by analyzing a retrospective cohort.Methods: This study, conducted at Karolinska University Hospital, includes 331 women who donated ovarian biopsies during elective caesarean sections (2016–2022), compared to 2237 women who underwent the same procedure without donating tissue. The study group ranged in age from 21.5 to 46.8 years, while the reference group ranged from 15.3 to 56.3 years. Surgical and patient data were extracted from medical records (study group: September 2022–March 2023) and the Swedish Pregnancy Registry (reference group: November 2023). All data were pseudonymized to ensure confidentiality.Results: Our analysis indicates that ovarian biopsy collection is safe, with no significant increase in bleeding or hospitalization time. Furthermore, women who donated biopsies showed no significant differences in health characteristics compared to those who did not. However, due to the relatively recent start of the cohort, no long‐term follow‐up analysis could be conducted, which is a limitation of this study.Conclusion: Overall, our findings suggest that ovarian tissue biopsies collected during elective caesarean sections are both safe and representative, supporting their use in research to enhance our understanding of human ovarian biology.

8 June 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
LMLoren Méar
Loren Méar
JHJasmin Hassan
Jasmin Hassan
MMMatthew William Myers
Matthew William Myers
HTHosein Toosi
Hosein Toosi
IRIlmatar Rooda
Ilmatar Rooda
PDPauliina Damdimopoulou
Pauliina Damdimopoulou
Ovarian tissue cryopreservation enables fertility preservation in females undergoing gonadotoxic therapies, restoring fertility in adults. Although offered even before puberty, the childhood ovary and its vulnerability to therapy remain poorly characterized. Here, ovarian tissue from 16 patients undergoing fertility preservation (aged 1-16 years) and 11 adult controls (aged 22-32 years) was analyzed using single-cell RNA sequencing, spatial transcriptomics, and multiplex immunostaining. In chemotherapy-naive samples, 13 somatic cell populations underwent extracellular matrix remodeling, vascular, neural, and stromal maturation during puberty, whereas changes in germline related to chromatin remodeling. Spatial transcriptomics resolved 23 clusters across, revealing distinct tissue organization and follicular niche composition between children and adults. Chemotherapy exposure depleted perifollicular and vascular cells, suppressed intercellular signaling, and dysregulated over half of puberty-associated genes, converging on stress responses and extracellular matrix remodeling, with SEPTIN7 as a potential biomarker. These findings uncover critical developmental vulnerabilities of the pediatric ovary relevant to fertility preservation.